Wednesday, April 6, 2011

Oraya Therapeutics Raises $15.875M

Newark, California-based Oraya Therapeutics, a developer of noninvasive, robotically controlled systems for treating eye disorders, has raised another $15.875M in funding, according to a regulatory filing by the firm. The round comes on $5.0M raised in December, for a total of $20.875M in its latest round. Details on the new funding have not been disclosed by the company. Oraya's products are aimed at treating wet age-related macular degeneration (AMD). More information »